Art. 14 Regulation (EU) 2022/20

Fees

In forcesince 7 Jan 2022

Member States may levy a fee when they carry out safety assessment activities as a safety assessing Member State and establish reduced fees for non-commercial clinical trials in accordance with Article 86 of Regulation (EU) No 536/2014.